Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-31

Clinical Trial Update: Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye [Phase 2]

View source ↗

Summary

Completed Phase 2 study evaluating the safety and efficacy of delivering dexamethasone phosphate to the eye via iontophoresis for dry eye syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone Phosphate (dexamethasone phosphate)

Snippet

Sponsor: Eyegate Pharmaceuticals, Inc. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED